Biotechnology
Innovent Announced 2021 Interim Results with Total Revenue of RMB 1,941.8 Million and Accelerated Global R&D Footprint
SAN FRANCISCO and SUZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-08-25 20:53
5893
Tigermed Reports 2021 Interim Results with Strong Financial Growth
HANGZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (stock code: 300347.SZ / 3347.HK), a leading provider of innovative clinical research solutions for biopharmaceutical and medical device industry, reports its interim results for the six months endedJune 30, 202...
2021-08-25 20:49
6879
ExoCoBio to Build the World's First Clinical Grade Exosome GMP Manufacturing Facility
* $20 million investment for a new Mfg & R&D facility * Strategic platform for partnering & CDMO business SEOUL, South Korea, Aug. 25, 2021 /PRNewswire/ -- ExoCoBio Inc., the 4th largest exosome player in the world, announced the initiation of its "Project EGMP", starting with the constructio...
2021-08-25 19:44
3494
Angel Yeast Announces Acquisition of Bio Sunkeen's Yeast Relevant Assets
YICHANG, China, Aug. 25, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast
")(en.angelyeast.com
2021-08-25 19:35
5119
Global Cord Blood Corporation to Report First Quarter Fiscal 2022 Financial Results
HONG KONG, Aug. 25, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...
2021-08-25 19:00
3982
Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial Evaluating Combination BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients
DURHAM, N.C. and BEIJING, Aug. 25, 2021 /PRNewswire/ -- Brii Biosciences
2021-08-25 08:42
3804
Advanced Sterilization Products Announces Launch in Asia Pacific of The Fastest Biological Indicator For Hydrogen Peroxide Sterilization
SINGAPORE, Aug. 25, 2021 /PRNewswire/ -- Advanced Sterilization Products (ASP)
announced today that the STERRAD VELOCITY™ Biological Indicator (BI)/Process
Challenge Device (PCD) 15-minute time to result will be commercially available
in theAsia Pacific region# from 25 August 2021.
2021-08-25 08:10
4271
Athos Therapeutics Announces Research Collaboration with Cleveland Clinic to Advance Precision Medicine in Inflammatory Bowel Disease
LOS ANGELES, Aug. 25, 2021 /PRNewswire/ -- Athos Therapeutics, Inc., a late preclinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with immune-mediated diseases, announced today a comprehensive Master Research Agreement for a coll...
2021-08-25 01:00
3503
GenScript Biotech Reports First Half 2021 Results
* In the first half of 2021, the Group reported a revenue of approximately USD 229.6 million, a 38.0% YoY increase, and a gross profit of USD 138.6 million , achieving a 28.1% YoY growth. All four of the Group's business segments demonstrated steady growth. * Building on early strategic invest...
2021-08-24 21:38
6934
ASX Announcement: AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics
Highlights: * AdAlta and Carina Biotech enter a collaboration agreement to develop i-body enabled CAR-T cancer immunotherapies against up to five solid tumour antigen targets * Combining Carina's advanced CAR-T platform technologies with AdAlta's i–body targeting capability aims to create un...
2021-08-24 19:26
2508
Ascentage Pharma Announces 2021 Interim Results Highlighting the Potential of Its Core Drug Candidates and Major Breakthroughs in Strategic Collaborations
SUZHOU, China, and ROCKVILLE, Md., Aug. 24, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its 2021 interim results and released an updat...
2021-08-24 19:06
3970
Kintor Pharma to Report 2021 Interim Financial Results and Host Conference Call on August 30, 2021
SUZHOU, China, Aug. 24, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today the company will review the interim results and business highlights on...
2021-08-24 17:04
2747
China Medical System Holdings Limited 2021 Interim Results Announcement
Business Performance Reached Record High Turnover Increased by 23.6% to RMB3,843.0 Million Profit Increased by 25.5% to RMB1,631.6 Million Industrial Investment Enables Innovation Incubation New Businesses Boost Future Development Financial Highlights For the 6 months ended 30 June 2021 (RMB ...
2021-08-24 10:52
4449
Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in China
SHANGHAI and HONG KONG, Aug. 24, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...
2021-08-24 08:30
3641
Genscript Biotech Reports 2021 Interim Financial Results
Strong Momentum across All Business Segments, particularly in Gene & Cell Therapy CDMO Continue to accelerate R&D investment to capture Future Growth * Revenue of the Group for the six months ended June 30, 2021 was approximately US$229.6 million, representing an increase of 38.0% as compared...
2021-08-24 01:32
4683
Himalaya Therapeutics Announces Registration of its Office in Shanghai
SHANGHAI and SAN DIEGO, Aug. 23, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China, of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, wh...
2021-08-23 22:10
2583
Hepagene Therapeutics, Inc. Announces Positive Results from Phase I Trial of HPG1860
SHANGHAI, Aug. 23, 2021 /PRNewswire/ -- Hepagene Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on novel therapies for patients with liver diseases, today announced positive results from its Phase I study of HPG1860 conducted inthe United States. HPG1860 is a non-bile aci...
2021-08-23 22:00
1941
Excelra launches a re-envisioned version of GOSTAR, its structure-activity relationship application, with an innovative set of new features to accelerate the drug discovery cycle
HYDERABAD, India, Aug. 23, 2021 /PRNewswire/ -- Today, Excelra
2021-08-23 21:00
3924
WuXi Biologics Reports Strong 2021 Interim Results
* Revenue Increases by 126.7% Y-o-Y to RMB4,406.8 Million * Gross Profit Grows by 191.7% Y-o-Y to RMB2,296.8 Million * Adjusted Net Profit Attributable to Owners of the Company Increases by 163.0% Y-o-Y toRMB1,768.7 Million * Gross and Net Profit Margins Reach 52.1% and 42.7%, Respectively ...
2021-08-23 20:59
4830
Study Confirms Viraleze Antiviral Nasal Spray Provides Protection Against SARS-CoV-2 in Challenge Model
MELBOURNE, Australia, Aug. 23, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma has announced the publication of new data demonstrating the capability of its Viraleze antiviral nasal spray to protect against SARS-CoV-2 in an animal challenge model of SARS-CoV-2 infection[1]. Viraleze adm...
2021-08-23 20:23
4925
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity
[Picked up by 279 media titles]
2026-05-19 14:00
Most Read
NYSE Content Update: Lincoln International Pops by 13% in First Day of Trade
2026-05-21 21:04
7938
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
7746
IBM and U.S. Department of Commerce Announce America's First Purpose-Built Quantum Foundry, Supported by Proposed $1 Billion CHIPS Award
2026-05-21 20:11
6876
/C O R R E C T I O N -- The American Chamber of Commerce in Singapore (AmChamSG)/
2026-05-21 12:14
6773
